With our continuous growth over the years, we have established a diversified product portfolio comprising products for the treatment of oncology diseases, central nervous system diseases, autoimmune diseases, cardiovascular diseases, and infectious diseases. As of December 31, 2019, more than 20 of our products have been included in the national medical insurance drug directory.
oncology
central nervous system diseases
autoimmune diseases
cardiovascular diseases
anti-infective
other therapeutic areas